Ex parte LANDA - Page 3




          Appeal No. 1996-2362                                                        
          Application No. 08/203,596                                                  

               We will not sustain this rejection for the reasons fully               
          detailed by the appellant in the brief and reply brief.  We                 
          add the following comments for emphasis.                                    
               In support of his nonenablement position regarding the                 
          here claimed polymers, the examiner argues that “[t]here is no              
          way of determining, without individually testing every single               
          one of these polymers, whether it would be suitable as a                    
          liquid toner and whether it meets the limitations of                        
          Appellant’s claim” (answer, page 8).  However, even if this                 
          argument is factually sound, it does not militate against                   
          enablement.  This is because the enablement criteria of                     
          section 112 simply does not require the capability of                       
          determining suitability in the absence of testing.  As the                  
          appellant has repeatedly explained, such a requirement would                
          render all “experimentation” “undue”, since “experimentation”               
          implies that the success of a particular activity is                        
          uncertain.  In re Angstadt, 537 F.2d 498, 503, 190 USPQ 214,                
          218-219 (CCPA 1976).  Furthermore, it is well settled that                  
          some experimentation is permissible under the enablement                    
          requirement of section 112.  Fields v. Conover, 443 F.2d 1386,              
          1390-1391, 170 USPQ 276, 279 (CCPA 1971).                                   

                                          3                                           





Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007